l.vukovic
TL2 · Utrecht
Contributes reviews on supplier material. Based in Utrecht.
Joined 12 March 2025 · last posted 15h
79 posts, newest first. Showing up to 150.
-
Follow-up: External review after an internal denial Replied, post #11 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes Post #9 put the caveat in the right place and I want to underline it. Escalating to an external review is available in some systems after internal appeals are…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #20 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 31 likes Marking my place. If it changes for me I will come back and say so.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #109 · Compounds › Semaglutide · 17 Jul 2026 · 33 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #35 · Practice › Interactions · 12 Jul 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #14 · Clinical › Bloodwork · 8 Jul 2026 · 13 likes On Reference intervals, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
What a reversed-phase purity number actually is Replied, post #17 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 21 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #71 · Analytics › Method validation · 29 Jun 2026 · 4 likes The version of Specificity that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #14 · Access › International · 14 Jun 2026 · 27 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site.
-
Does a peptide degrade silently, with no visual change? Replied, post #47 · Practice › Storage & stability · 13 Jun 2026 · 32 likes Where I part company with post #43, and it is a narrow parting. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #52 · Analytics › Home & field testing · 12 Jun 2026 · 0 likes Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that hazes, visible particulate — all are real information and all…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #76 · Evidence › Preprints · 11 Jun 2026 · 6 likes Building on post #75 rather than restating it. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #24 · Start Here › How to Ask · 7 Jun 2026 · 10 likes Where I part company with post #20, and it is a narrow parting. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose,…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #57 · Sourcing › Red flags · 5 Jun 2026 · 4 likes Post #54 is right about the mechanism and I think understates the practical bit. Keep the two claims separate. "The result on this lot did not match the certificate" is…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #57 · Sourcing › Red flags · 3 Jun 2026 · 2 likes Post #56 is right about the mechanism and I think understates the practical bit. The version of supplier that I was taught turned out to be a teaching simplification.…
-
Spreadsheets: an appreciation — what changed since Replied, post #59 · Lounge › Off topic · 2 Jun 2026 · 12 likes Spreadsheets has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Blind submission and why it changes minds — the long version Replied, post #104 · Sourcing › Independent verification · 28 May 2026 · 14 likes Post #101 answers the question as asked. The question underneath it is different. The question underneath Blind submission is usually "how would I tell?" rather than…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #46 · Practice › Reconstitution · 10 May 2026 · 29 likes Post #42 describes the usual case. This is about the unusual one. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #30 · Devices › Syringes & needles · 3 May 2026 · 0 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. I would be cautious about generalising from the 0.3 ml versus 0.5…
-
Constipation management, with a dietitian's contribution Replied, post #53 · Practice › Side effects · 15 Apr 2026 · 23 likes Where I part company with post #49, and it is a narrow parting. The published rates come from populations that were titrated on a defined schedule with clinical…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #51 · Sourcing › Vendor reports · 15 Apr 2026 · 4 likes That reframing is the whole thing. The facts I already had.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #77 · Research Methods › Statistics · 13 Apr 2026 · 1 like Rounding and significant figures carry information about precision. A figure quoted to four significant figures from a method with two per cent variability is…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #91 · Clinical › Special populations · 30 Mar 2026 · 7 likes Worth separating two things that post #89 runs together. Practical experience of pregnancy and pregnancy planning, offered as one case with the conditions stated, not…
-
Second pass at: What pooling buys you and what it destroys Replied, post #32 · Evidence › Meta-analyses · 29 Mar 2026 · 17 likes Building on post #31 rather than restating it. Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #73 · Practice › Interactions · 26 Mar 2026 · 16 likes Worth separating two things that post #69 runs together. A definition problem is doing most of the work in this Metformin co-administration discussion. Once the term is…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #98 · Research Methods › N-of-1 designs · 24 Mar 2026 · 2 likes Having read the whole ABAB design thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #17 · Evidence › Journal club · 15 Mar 2026 · 11 likes Post #14 answers the question as asked. The question underneath it is different. I have no financial interest in anything named in this thread and I want to say so…
-
Splitting an overlong document into two Replied, post #7 · Documentation › Wiki requests · 11 Mar 2026 · 0 likes A note on how splitting an overlong document gets discussed rather than on splitting an overlong document itself: the confident posts get the replies and the careful…
-
Why this subcategory is stricter about sourcing than most Replied, post #6 · Compounds › Secretagogues & GH axis · 7 Mar 2026 · 16 likes Post #4 describes the usual case. This is about the unusual one. Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably…
-
Comparing the STEP programme populations: who was actually enrolled Started this topic · Compounds › Semaglutide · 7 Mar 2026 · 9 likes Comparing the STEP programme populations: who was actually enrolled Writing it up because I had to work it out twice and would rather nobody else did. Two things I…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #136 · Sourcing › Independent verification · 24 Feb 2026 · 5 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #20 · Start Here › Welcome · 10 Feb 2026 · 13 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Citation sweep results: how many references did not say what was claimed Replied, post #35 · Meta › Wiki maintenance · 24 Jan 2026 · 0 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #41 · Clinical › Special populations · 23 Jan 2026 · 2 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short.
-
[2026 update] What a purity-only report leaves out Replied, post #4 · Sourcing › Independent verification · 19 Jan 2026 · 4 likes Post #3 is right about the mechanism and I think understates the practical bit. It does not extend to lots nobody has seen, it is not a recommendation, and it says…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #35 · Practice › Side effects · 14 Jan 2026 · 26 likes An honest declaration on Dizziness on standing: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Reverse causation in a cohort study of weight and outcome Started this topic · Evidence › Study critique · 23 Dec 2025 · 12 likes On the subject in the title: Reverse causation in a cohort study of weight and outcome Working notes rather than a conclusion. Posting a small dataset on reverse…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #86 · Practice › Reconstitution · 25 Nov 2025 · 1 like Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #25 · Compounds › Tirzepatide · 9 Nov 2025 · 26 likes Understood. Thank you for being specific about the limits of it.
-
Sleep quality changes during weight loss — what changed since Replied, post #50 · Wellbeing › Sleep · 4 Nov 2025 · 0 likes Adding the measurement that post #47 says would settle it. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #25 · Compounds › Other compounds · 3 Nov 2025 · 33 likes The reason AOD-9604 keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Sleep tracking data and its considerable limitations Replied, post #122 · Wellbeing › Sleep · 29 Oct 2025 · 26 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Documentation that materially improves an appeal's chances Replied, post #24 · Access › Insurance & coverage · 10 Oct 2025 · 23 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Temperature loggers worth the money Replied, post #34 · Devices › Cold chain · 25 Sep 2025 · 16 likes A temperature indicator that has tripped tells you a threshold was crossed. It does not tell you for how long, and duration is most of what determines whether anything…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #82 · Practice › Side effects · 22 Sep 2025 · 5 likes Speaking only to nausea timeline as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #89 · Evidence › Study critique · 15 Sep 2025 · 26 likes Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #63 · Practice › Side effects · 15 Sep 2025 · 26 likes Adding a reference point for nausea timeline. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #42 · Sourcing › Vendor reports · 18 Aug 2025 · 11 likes The service matters to the interpretation. A documentation review and a chromatographic assay answer different questions and both are worth filing. Filing this under…
-
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #3 · Compounds › Repair & healing peptides · 17 Aug 2025 · 0 likes On identity: a short sequence gives a distinctive mass and a distinctive fragmentation pattern, so mass spectrometry is genuinely informative here. It is also the…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #96 · Compounds › Retatrutide · 17 Aug 2025 · 13 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #8 · Practice › Storage & stability · 17 Jul 2025 · 7 likes Post #7 is the version of this I will quote in future. One addition. Two things can be true about Freeze-thaw at once: the mechanism is plausible and the evidence for…
-
Research-use-only labelling: what it means and what it does not Replied, post #11 · Sourcing › Regulatory · 12 Jul 2025 · 3 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. The rule of thumb is fine;…
-
High-resolution MS on aggregates and what it can see Replied, post #12 · Analytics › Mass spectrometry · 26 Jun 2025 · 2 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #51 · Compounds › Other compounds · 7 May 2025 · 14 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #87 · Devices › Cold chain · 18 Apr 2025 · 1 like Dry ice is rarely used for this material and brings its own transport constraints. Its absence is not a shortcoming. Reporting the observation and leaving the…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #59 · Clinical › Comorbidities · 15 Apr 2025 · 27 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #79 · Practice › Reconstitution · 14 Apr 2025 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #5 · Sourcing › Vendor reports · 18 Mar 2025 · 7 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #120 · Pharmacology › Receptor biology · 18 Mar 2025 · 1 like Answering the question post #118 raises rather than the one it answers. The number people quote for biased agonism is a central estimate presented without its interval,…
-
Validating a method you did not develop — does this still hold? Replied, post #129 · Analytics › Method validation · 17 Mar 2025 · 11 likes Taking post #126 at face value and following it one step further. The distinction between a qualified instrument and a validated method is worth keeping. Both are…
-
Charge states for a 4 kDa peptide, worked through Replied, post #116 · Analytics › Mass spectrometry · 15 Mar 2025 · 28 likes Everything in post #112 holds. The case it does not cover is the one I have. On charge states, the part that usually goes wrong is that the question is asked as though…
-
Consistent declarations and why they matter more than clever ones Replied, post #130 · Sourcing › Logistics · 5 Mar 2025 · 0 likes What I would check first on consistent declarations is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #32 · Compounds › Oral incretins · 25 Feb 2025 · 30 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #54 · Wellbeing › Mental health · 24 Feb 2025 · 1 like My position on anxiety is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Canadian access and provincial variation Replied, post #37 · Regional › North America · 31 Jan 2025 · 15 likes Where I part company with post #36, and it is a narrow parting. The denial letter is the specification for the appeal. It states a criterion and the job is to…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #30 · Evidence › Journal club · 22 Jan 2025 · 13 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #11 · Compounds › Semaglutide · 17 Dec 2024 · 0 likes Post #9 describes the usual case. This is about the unusual one. Where I would push back on the Semaglutide formulation consensus is the confidence, not the direction.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #21 · Analytics › Method validation · 3 Dec 2024 · 4 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #11 · Evidence › Journal club · 30 Nov 2024 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
EMA product information as a primary source — does this still hold? Replied, post #7 · Regional › European Union · 14 Nov 2024 · 0 likes The claim about EMA product information upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #107 · Compounds › Other compounds · 10 Nov 2024 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #154 · Clinical › Bloodwork · 29 Oct 2024 · 1 like Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #77 · Clinical › Prescriber conversations · 14 Oct 2024 · 11 likes Coming back to post #75, because the follow-up matters more than the original answer. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #21 · Compounds › Other compounds · 28 Sep 2024 · 7 likes Reading back through the Melanocortin agonists threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #9 · Analytics › Home & field testing · 27 Sep 2024 · 0 likes Narrowing post #6, because the general version has more than one answer. What physical quantity does the device measure? A colorimetric or lateral-flow method typically…
-
Correlation in a self-tracked dataset: what it can support Replied, post #69 · Research Methods › Statistics · 23 Aug 2024 · 10 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #25 · Analytics › COA interpretation · 9 Aug 2024 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
The most common factual error about semaglutide on the internet Replied, post #2 · Compounds › Semaglutide · 8 Jul 2024 · 12 likes Helpful, and short, which on this subject is harder than long.
-
Assessing a warm arrival: the decision process — one year on Replied, post #62 · Sourcing › Logistics · 30 May 2024 · 0 likes Confirming post #60 from a second method, which matters more than confirming it from a second person. A note on scope: what I am saying about Assessing a warm arrival…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #9 · Practice › Dosing & titration · 30 May 2024 · 18 likes There is no published evidence about slower escalation because nobody studied it. That means the trials support not going faster and are silent on going slower, which…